Paraganglioma
📧 Sign up to get email alerts when something new happens for Paraganglioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma [Phase 2]
A Phase 2 clinical trial evaluating Lutathera (Lutetium-177 DOTATATE) for inoperable pheochromocytoma and paraganglioma is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)
Clinical trial update from Italy describes multicenter experience with radioreceptor-assisted therapy (PRRT) for pheochromocytoma and paraga…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) [Phase 2]
This Phase 2 trial update covers belzutifan (MK-6482) for advanced pheochromocytoma/paraganglioma, pancreatic neuroendocrine tumors, von Hip…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors [Phase 1, Phase 2]
Perspective Therapeutics is recruiting for a Phase 1/Phase 2 study of targeted alpha-particle therapy for advanced SSTR2-positive neuroendoc…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Lutathera (177Lu-DOTATATE) in combination with Olaparib for somatostatin receptor–expressing recurrent…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer [Phase 2]
A phase 2 clinical trial is evaluating adding olaparib to temozolomide for advanced pheochromocytoma and paraganglioma (neuroendocrine tumor…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Prospective Cohort Study of Pheochromocytoma/Paraganglioma
A prospective cohort study on pheochromocytoma and paraganglioma sponsored by Peking Union Medical College Hospital is currently not yet rec…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma [Phase 2]
A Phase 2 clinical trial evaluating iodine-131 labeled metaiodobenzylguanidine (MIBG) in patients with recurrent or refractory neuroblastoma…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy [Phase 1, Phase 2]
Recruitment is ongoing for a Phase 1/2 study of the radiopharmaceutical [212Pb]VMT-alpha-NET targeting somatostatin receptors in metastatic …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma [Phase 2]
A Phase 2 clinical trial investigates Axitinib, a VEGF-pathway inhibitor, in patients with pheochromocytoma and paraganglioma; the study sta…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) [Phase 2]
Phase 2 clinical trial update for lanreotide in metastatic pheochromocytoma and paraganglioma (LAMPARA); trial status is ACTIVE_NOT_RECRUITI…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma [Phase 2]
Phase 2 clinical trial studying ONC206 (JZP3507) in adults with advanced pheochromocytoma and paraganglioma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma [EARLY_Phase 1]
Early-phase 1 imaging study evaluating PARP-1 expression using 18F-FluorThanatrace PET/CT in patients with pheochromocytoma and paragangliom…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)
A completed clinical study describing the development and clinical application of a novel imaging grading system for pheochromocytoma and pa…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma [NA]
A completed clinical trial from University Hospital, Rouen evaluated the specificity of elevated plasma EM66 levels for pheochromocytoma and…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma [Phase 1, Phase 2]
Clinical trial update for EO2401 in metastatic adrenocortical carcinoma and malignant pheochromocytoma/paraganglioma reports termination of …
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas
This clinical trial update describes a multicenter study evaluating cardiovascular and metabolic complications in patients with biochemicall…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma [NA]
A clinical trial is evaluating the PET/CT tracer Al18F-NOTA-LM3 in patients with pheochromocytoma and paraganglioma, and the study is curren…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers [Phase 1]
Phase 1 trial evaluating the radiopharmaceutical [212Pb]VMT-Alpha-NET across multiple somatostatin receptor–positive cancers, with recruitme…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. [Phase 4]
A Phase 4 clinical trial evaluating the use of the radiotracer 68-Gallium DOTATATE PET/MRI for diagnosing and managing somatostatin receptor…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial [Phase 2]
Phase 2 trial evaluating the combination of talazoparib and temozolomide in advanced, rare cancers; the study is currently active but not re…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
A clinical study sponsored by The University of Texas Health Science Center at San Antonio is investigating genetic analysis of pheochromocy…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
A clinical trial evaluating imaging agents targeting somatostatin receptors and norepinephrine transporters for diagnosis and staging of neu…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors
This document reports enrollment status for a comparative study of perioperative cardiac injury in patients with functional adrenal tumors, …
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial [Phase 2]
Phase 2 BELIEVE-VHL trial is assessing real-world effectiveness and pharmacogenetics of belzutifan in Von Hippel-Lindau syndrome; recruitmen…